.

Roberto Imberti1

  • 1Direzione Scientifica, Phase I Clinical Trials Unit and Experimental Therapy, Fondazione IRCCS Policlinico, San Matteo, Pavia, Italy.

概括

开发用于创伤性脑损伤 (TBI) 的新药需要改变范式. 探索超越传统措施的替代临床终点可能会鼓励制药公司对TBI治疗的投资.